Cancer Research Infection and Cancer: Biology, Therapeutics, and Prevention  Tumor Immunology: New Perspectives
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 48, 3954-3958, July 15, 1988]
© 1988 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Brandes, L. J.
Right arrow Articles by LaBella, F. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Brandes, L. J.
Right arrow Articles by LaBella, F. S.

Correlation of the Antiproliferative Action of Diphenylmethane-Derivative Antiestrogen Binding Site Ligands with Antagonism of Histamine Binding but not of Protein Kinase C-mediated Phosphorylation1

Lorne J. Brandes2, Jon M. Gerrard, R. Patricia Bogdanovic, Don W. Lint, Ronald E. Reid and Frank S. LaBella

Departments of Medicine [L. J. B.], Pharmacology and Therapeutics [L. J. B., F. S. L.], and Pediatrics [J. M. G.], Faculties of Medicine and Pharmacy [R. E. R.], and the Manitoba Institute of Cell Biology [L. J. B., J. M. G., R. P. B., D. W. L.], University of Manitoba, Winnipeg, Manitoba, R3E 0V9 Canada

The nonestrogen receptor-mediated antiproliferative action of antiestrogen binding site (AEBS) ligands, including triphenylethylene antiestrogens and phenothiazines, has been linked to their ability to inhibit protein kinase C (PKC). Recent studies indicate that some diphenylmethane derivatives inhibit growth, are potent AEBS ligands, and antagonize histamine binding at an AEBS-related histamine site different from H1 and H2. Three novel diphenylmethane derivatives, N,N-diethyl-2-[4-(phenylmethyl)phenoxyl]ethanamine·HCl (DPPE), 4-decanoyl-DPPE (dec-DPPE), and 4-benzylphenyl decanoate (BPD) were studied in an attempt to determine whether PKC or histamine interactions best correlate with their antiproliferative effects. Platelet aggregation and the phosphorylation of a platelet Mr 47,000 protein (p47) induced by phorbol-12-myristate-13-acetate (PMA) represent two processes mediated by PKC. DPPE inhibits PMA-induced aggregation [50% inhibitor concentration (IC50) = 31.2 ± 2.4 (SEM) x 10-6 M] but does not significantly inhibit either PMA-induced phosphorylation of Mr 47,000 protein (IC50 > 500 x 10-6 M), or binding of [3H]phorbol dibutyrate to platelets. dec-DPPE is a more potent inhibitor of PMA-induced platelet aggregation (IC50 = 18.8 ± 0.7 x 10-6 M), a weak inhibitor of Mr 47,000 phosphorylation (IC50 = 80–200 x 10-6 M), but is without effect on [3H] phorbol dibutyrate binding. BPD, which lacks the alkylaminoethoxy side chain necessary for binding to the AEBS/DPPE site, is devoid of anti-PMA effects. These results are compared to the inhibition of [3H]histamine binding in rat cortex membranes (K1 value for DPPE = 0.83 ± 0.62 x 10-6 M; K1 value for dec-DPPE = 6.6 ± 3.5 x 10-6 M; BPD is inactive) and growth inhibition of MCF-7 cells (IC50 value for DPPE = 4.5 x 10-6 M; IC50 value for dec-DPPE = 1.5 x 10-5 M; BPD is ineffective at all concentrations tested). Thus, while dec-DPPE is a more potent inhibitor of PKC-mediated phosphorylation, DPPE is a more potent inhibitor of histamine binding and is correspondingly more antiproliferative than dec-DPPE. The results support a relationship between antagonism of histamine binding and growth inhibition but argue against an association between the antiproliferative effects of DPPE and dec-DPPE and inhibition of PKC. The findings for DPPE suggest that platelet response to PMA, antagonized by diphenylmethane-type AEBS-ligands, may be mediated, at least in part, by mechanisms other than activation of protein kinase C-dependent phosphorylation.

1 This work was supported by grants from the Manitoba Health Research Council, The University of Manitoba Faculty Fund, The Medical Research Council of Canada, and by a generous gift from the estate of Morris Katz.

2 To whom requests for reprints should be addressed.

Received 1/25/88. Revised 4/ 7/88. Accepted 4/11/88.




This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
B. Kedjouar, P. de Medina, M. Oulad-Abdelghani, B. Payre, S. Silvente-Poirot, G. Favre, J.-C. Faye, and M. Poirot
Molecular Characterization of the Microsomal Tamoxifen Binding Site
J. Biol. Chem., August 6, 2004; 279(32): 34048 - 34061.
[Abstract] [Full Text] [PDF]


Home page
ScienceHome page
S. Saxena, L. Brandes, A. Becker, K. Simons, F. LaBella, and J. Gerrard
Histamine is an intracellular messenger mediating platelet aggregation
Science, March 24, 1989; 243(4898): 1596 - 1599.
[Abstract] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1988 by the American Association for Cancer Research.